Alpine Global Management’s AbbVie ABBV Stock Holding History

Alpine Global Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,529	Closed	-$278K	–	463
2024 Q1	$278K	Buy	+1,529	New	+$264K	0.05%	145
2019 Q3	–	Sell	-27,000	Closed	-$1.96M	–	83
2019 Q2	$1.96M	Buy	+27,000	New	+$2.12M	0.57%	27
2017 Q2	–	Sell	-8,797	Closed	-$573K	–	128
2017 Q1	$573K	Buy	+8,797	New	+$553K	0.15%	116
2015 Q3	–	Sell	-6,830	Closed	-$459K	–	90
2015 Q2	$459K	Sell	6,830 -9,239	-57%	-$603K	0.08%	190
2015 Q1	$941K	Sell	16,069 -18,857	-54%	-$1.14M	0.31%	76
2014 Q4	$2.29M	Buy	+34,926	New	+$2.2M	0.41%	59

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpine Global Management's ABBV Position: Q2 2024 in Review

Alpine Global Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 1,529 shares — an estimated $278K sold.

Alpine Global Management first reported a position in ABBV in Q4 2014 and held it in 6 quarters. The position peaked at $2.29M in Q4 2014. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Alpine Global Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Alpine Global Management sold 1,529 AbbVie shares in Q2 2024, an estimated $278K.
Alpine Global Management first reported a position in AbbVie in Q4 2014 and held it in 6 quarters.
Alpine Global Management's AbbVie position peaked at $2.29M in Q4 2014.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.